New cell therapy injection enters final testing for severe eczema
NCT ID NCT07377838
Summary
This study is testing whether an experimental injection called ADSTEM can help control moderate-to-severe atopic dermatitis (eczema) in adults. Researchers will compare ADSTEM against a placebo injection in 286 participants whose eczema hasn't responded well to standard treatments. The main goal is to see if the treatment significantly clears skin and reduces eczema severity over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.